Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Raw Materials (2016 - 2025)

Historic Raw Materials for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $96.2 million.

  • Bio-Techne's Raw Materials rose 1458.19% to $96.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $96.2 million, marking a year-over-year increase of 1458.19%. This contributed to the annual value of $89.1 million for FY2025, which is 1222.39% up from last year.
  • Per Bio-Techne's latest filing, its Raw Materials stood at $96.2 million for Q4 2025, which was up 1458.19% from $94.0 million recorded in Q3 2025.
  • Bio-Techne's Raw Materials' 5-year high stood at $96.2 million during Q4 2025, with a 5-year trough of $51.7 million in Q1 2021.
  • For the 5-year period, Bio-Techne's Raw Materials averaged around $78.2 million, with its median value being $82.5 million (2023).
  • Per our database at Business Quant, Bio-Techne's Raw Materials skyrocketed by 4391.43% in 2022 and then tumbled by 745.01% in 2024.
  • Quarter analysis of 5 years shows Bio-Techne's Raw Materials stood at $61.6 million in 2021, then surged by 37.54% to $84.8 million in 2022, then dropped by 1.78% to $83.2 million in 2023, then rose by 0.86% to $84.0 million in 2024, then increased by 14.58% to $96.2 million in 2025.
  • Its last three reported values are $96.2 million in Q4 2025, $94.0 million for Q3 2025, and $89.1 million during Q2 2025.